Search Within

Alexander Edward Drilon

Formats
  1. Meeting Abstract (374)
  2. Journal Article (226)
  3. Review (23)
  4. Editorial (6)
  5. Correspondence (3)
  6. Book Section (2)
  7. Research Letter (2)
  8. Book Whole (1)
  9. Guidelines (1)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (639)
  2. Solid Tumor Oncology Division (639)
  3. Thoracic Oncology (639)
  4. Department of Pathology and Laboratory Medicine (210)
  5. GSK Faculty (191)
  6. Hematology-Oncology Fellows (186)

More Groups

People
  1. Marc Ladanyi (123)
  2. Mark Kris (91)
  3. Maria Arcila (83)
  4. David Hyman (78)
  5. Bob Li (65)
  6. Charles Rudin (64)

More People

Years
  1. 2025 (23)
  2. 2024 (61)
  3. 2023 (68)
  4. 2022 (85)
  5. 2021 (76)
  6. 2020 (81)

More Years

Publications
  1. Journal of Clinical Oncology (138)
  2. Annals of Oncology (94)
  3. Journal of Thoracic Oncology (85)
  4. Clinical Cancer Research (31)
  5. JCO Precision Oncology (24)
  6. Cancer Research (23)

More Publications

Publishers
  1. American Society of Clinical Oncology (164)
  2. Elsevier Inc. (119)
  3. Oxford University Press (113)
  4. American Association for Cancer Research (78)
  5. Nature Publishing Group (27)
  6. S. Karger AG (23)

More Publishers

Results (639)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • RET mutations in neuroendocrine tumors: Including small-cell lung cancer
    Journal Article

    Rudin, C. M.; Drilon, A.; Poirier, J. T.
    Journal of Thoracic Oncology (2014)

    Fulltext@MSK | Save
  • A prospective study of tumor suppressor gene methylation as a prognostic biomarker in surgically resected stage i to IIIA non-small-cell lung cancers
    Journal Article

    Drilon, A.; Sugita, H.; Sima, C. S.; Zauderer, M.; Rudin, C. M.; Kris, M. G.; Rusch, V. W.; Azzoli, C. G.
    Journal of Thoracic Oncology (2014)

    Fulltext@MSK | Save
  • Unsuspected collision of synchronous lung adenocarcinomas: A potential cause of aberrant driver mutation profiles
    Journal Article

    Rekhtman, N.; Borsu, L.; Reva, B.; Arcila, M.; Riely, G. J.; Ladanyi, M.; Drilon, A.
    Journal of Thoracic Oncology (2014)

    Fulltext@MSK | Save
  • Screening for RET and ROS1 fusions in an enriched cohort of pan-negative never-smokers with advanced lung adenocarcinomas to identify patients for treatment in targeted therapy trials
    Meeting Abstract

    Drilon, A. E. D.; Wang, L.; Hasanovic, A.; Joubert, P.; Kris, M. G.; Riely, G. J.; Ladanyi, M.; Rizvi, N. A.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Ret fusion-positive advanced lung cancers: Response to first-line chemotherapy and survival in comparison to ROS1 and ALK fusion-positive and EGFR- and KRAS-mutant lung cancers
    Meeting Abstract

    Drilon, A.; Wang, L.; Joubert, P.; Snyder, A.; Cho, E. J.; Riely, G.; Kris, M.; Ladanyi, M.; Rizvi, N.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Histological prognostic markers in squamous cell carcinoma of the lung
    Meeting Abstract

    Drilon, A.; Sima, C. S.; Paik, P. K.; Moreira, A. L.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • The prevalence of RET and ROS1 gene rearrangements in advanced lung adenocarcinomas pan-negative for other known drivers as revealed by FISH analysis
    Meeting Abstract

    Wang, L.; Islamdoust, N.; Drilon, A. E.; Rizvi, N.; Joubert, P.; Hasanovic, A.; Wynne, M.; Intrieri, J.; Jhanwar, S. C.; Ladanyi, M.
    Journal of Molecular Diagnostics (2013)

    Fulltext@MSK | Save
  • Response to cabozantinib in patients with RET fusion-positive lung adenocarcinomas
    Journal Article

    Drilon, A.; Wang, L.; Hasanovic, A.; Suehara, Y.; Lipson, D.; Stephens, P.; Ross, J.; Miller, V.; Ginsberg, M.; Zakowski, M. F.; more...
    Cancer Discovery (2013)

    Fulltext@MSK | Save
  • Local therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors
    Meeting Abstract

    Yu, H. A.; Sima, C. S.; Drilon, A. E. D.; Varghese, A. M.; Pietanza, M. C.; Azzoli, C. G.; Rizvi, N. A.; Krug, L. M.; Kris, M. G.; Miller, V. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Comparison of the KRAS/EGFR mutation profile and survival of "collegiate smokers" and never smokers with advanced lung cancers
    Meeting Abstract

    Varghese, A. M.; Sima, C. S.; Chaft, J. E.; Johnson, M. L.; Janjigian, Y. Y.; Drilon, A. E. D.; Yu, H. A.; Riely, G. J.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save